Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Response evaluation--pathway for accurate indications development].

A Sendler1

  • 1Chirurgische Klinik und Poliklinik, Technische Universität München, Klinikum rechts der Isar, Ismaningerstrasse 22, 81675 München.

Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|February 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Gastric cancer and adenocarcinoma of the esophagogastric junction: principles of neoadjuvant therapy].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2011
Same author

[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].

Zeitschrift fur Gastroenterologie·2011
Same author

Metabolic response evaluation by PET during neoadjuvant treatment for adenocarcinoma of the esophagus and esophagogastric junction.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2010
Same author

Neoadjuvant treatment of adenocarcinomas of the gastroesophageal junction and stomach - a feasibility trial combining cisplatin and docetaxel with either 5-fluorouracil or capecitabine.

International journal of clinical pharmacology and therapeutics·2010
Same author

[Tumors of the upper gastro-intestinal tract].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2010
Same author

[Early Barrett's carcinoma/high grade intraepithelial neoplasia (HG-IEN): pro endoscopic treatment--pro surgical treatment].

Zeitschrift fur Gastroenterologie·2009
Same journal

[120th Congress of the German Surgical Society. 29 April-2 May 2003, Munich, Germany. Abstracts].

Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress·2004
Same journal

[Quality and economy--contradictory demands].

Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress·2003
Same journal

[Attractive work schedules--the Sinsheim model].

Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress·2003
Same journal

[Women research personnel also in advanced positions and how do women promote women in this manner?].

Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress·2003
Same journal

[Is surgery a male specialty?--Discussion of bias].

Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress·2003
Same journal

[Integrated clinical guidelines].

Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress·2003
See all related articles

Accurate response prediction using 18-fluorodeoxyglucose-positron emission tomography (18FDG-PET) is crucial for esophageal cancer patients undergoing neoadjuvant therapy. This method offers a reliable way to identify responders for improved survival outcomes.

Area of Science:

  • Oncology
  • Medical Imaging
  • Nuclear Medicine

Background:

  • Identifying patients who respond to neoadjuvant therapy is critical for improving survival in esophageal cancer.
  • Traditional response evaluation methods like endoscopy, biopsy, endoluminal ultrasound, and CT scans have shown unreliable results.
  • Accurate prediction of treatment response is essential for guiding clinical decisions and patient management.

Purpose of the Study:

  • To evaluate the potential of 18-fluorodeoxyglucose-positron emission tomography (18FDG-PET) for accurate response prediction in esophageal cancer patients.
  • To assess the feasibility of differentiating between responders and non-responders following neoadjuvant chemoradiation using 18FDG-PET.
  • To investigate early response differentiation after two weeks of therapy.

Main Methods:

Related Experiment Videos

  • Retrospective analysis of esophageal cancer patients undergoing neoadjuvant chemoradiation.
  • Utilizing 18FDG-PET imaging for response assessment.
  • Comparing imaging findings with treatment response and survival outcomes.

Main Results:

  • 18FDG-PET demonstrated a sensitive differentiation between responders and non-responders in a retrospective study.
  • This imaging modality shows promise for accurate response prediction following neoadjuvant therapy.
  • Ongoing investigations aim to differentiate responders as early as two weeks into treatment.

Conclusions:

  • 18FDG-PET is a promising tool for sensitive response evaluation in esophageal cancer patients treated with neoadjuvant therapy.
  • Accurate and early response prediction can significantly impact patient survival and treatment strategies.
  • Further prospective studies are warranted to validate these findings and establish 18FDG-PET as a standard clinical tool.